323 related articles for article (PubMed ID: 20858269)
1. MicroRNA roles in beta-catenin pathway.
Huang K; Zhang JX; Han L; You YP; Jiang T; Pu PY; Kang CS
Mol Cancer; 2010 Sep; 9():252. PubMed ID: 20858269
[TBL] [Abstract][Full Text] [Related]
2. Distinctive microRNA signature associated of neoplasms with the Wnt/β-catenin signaling pathway.
Sun X; He Y; Huang C; Ma TT; Li J
Cell Signal; 2013 Dec; 25(12):2805-11. PubMed ID: 24041653
[TBL] [Abstract][Full Text] [Related]
3. Role of regulatory miRNAs of the Wnt/ β-catenin signaling pathway in tumorigenesis of breast cancer.
Rahmani F; Tadayyon Tabrizi A; Hashemian P; Alijannejad S; Rahdar HA; Ferns GA; Hassanian SM; Shahidsales S; Avan A
Gene; 2020 Sep; 754():144892. PubMed ID: 32534060
[TBL] [Abstract][Full Text] [Related]
4. Convergence between Wnt-β-catenin and EGFR signaling in cancer.
Hu T; Li C
Mol Cancer; 2010 Sep; 9():236. PubMed ID: 20828404
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs target the Wnt/β‑catenin signaling pathway to regulate epithelial‑mesenchymal transition in cancer (Review).
Lei Y; Chen L; Zhang G; Shan A; Ye C; Liang B; Sun J; Liao X; Zhu C; Chen Y; Wang J; Zhang E; Deng L
Oncol Rep; 2020 Oct; 44(4):1299-1313. PubMed ID: 32700744
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-200a suppresses the Wnt/β-catenin signaling pathway by interacting with β-catenin.
Su J; Zhang A; Shi Z; Ma F; Pu P; Wang T; Zhang J; Kang C; Zhang Q
Int J Oncol; 2012 Apr; 40(4):1162-70. PubMed ID: 22211245
[TBL] [Abstract][Full Text] [Related]
7. Wnt/beta-catenin signaling in glioma.
Zhang K; Zhang J; Han L; Pu P; Kang C
J Neuroimmune Pharmacol; 2012 Dec; 7(4):740-9. PubMed ID: 22454041
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-27a-3p Modulates the Wnt/β-Catenin Signaling Pathway to Promote Epithelial-Mesenchymal Transition in Oral Squamous Carcinoma Stem Cells by Targeting SFRP1.
Qiao B; He BX; Cai JH; Tao Q; King-Yin Lam A
Sci Rep; 2017 Apr; 7():44688. PubMed ID: 28425477
[TBL] [Abstract][Full Text] [Related]
9. Mathematical modelling of Wnt/β-catenin signalling.
Kofahl B; Wolf J
Biochem Soc Trans; 2010 Oct; 38(5):1281-5. PubMed ID: 20863299
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic disruption of the WNT/beta-catenin signaling pathway in human cancers.
Ying Y; Tao Q
Epigenetics; 2009 Jul; 4(5):307-12. PubMed ID: 19633433
[TBL] [Abstract][Full Text] [Related]
11. miR-98 inhibits hepatocellular carcinoma cell proliferation via targeting EZH2 and suppressing Wnt/β-catenin signaling pathway.
Zhang JJ; Chen JT; Hua L; Yao KH; Wang CY
Biomed Pharmacother; 2017 Jan; 85():472-478. PubMed ID: 27890434
[TBL] [Abstract][Full Text] [Related]
12. Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities.
Liu J; Xiao Q; Xiao J; Niu C; Li Y; Zhang X; Zhou Z; Shu G; Yin G
Signal Transduct Target Ther; 2022 Jan; 7(1):3. PubMed ID: 34980884
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-1229 overexpression promotes cell proliferation and tumorigenicity and activates Wnt/β-catenin signaling in breast cancer.
Tan Z; Zheng H; Liu X; Zhang W; Zhu J; Wu G; Cao L; Song J; Wu S; Song L; Li J
Oncotarget; 2016 Apr; 7(17):24076-87. PubMed ID: 26992223
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-222 promotes tumorigenesis via targeting DKK2 and activating the Wnt/β-catenin signaling pathway.
Li Q; Shen K; Zhao Y; He X; Ma C; Wang L; Wang B; Liu J; Ma J
FEBS Lett; 2013 Jun; 587(12):1742-8. PubMed ID: 23587485
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic alterations of the Wnt/beta-catenin pathway in human disease.
Aguilera O; Muñoz A; Esteller M; Fraga MF
Endocr Metab Immune Disord Drug Targets; 2007 Mar; 7(1):13-21. PubMed ID: 17346200
[TBL] [Abstract][Full Text] [Related]
16. A Wnt-ow of opportunity: targeting the Wnt/beta-catenin pathway in breast cancer.
Prosperi JR; Goss KH
Curr Drug Targets; 2010 Sep; 11(9):1074-88. PubMed ID: 20545611
[TBL] [Abstract][Full Text] [Related]
17. New avenues to target Wnt/β-catenin signaling.
Verkaar F; Zaman GJ
Drug Discov Today; 2011 Jan; 16(1-2):35-41. PubMed ID: 21111060
[TBL] [Abstract][Full Text] [Related]
18. Effects of mutations in Wnt/β-catenin, hedgehog, Notch and PI3K pathways on GSK-3 activity-Diverse effects on cell growth, metabolism and cancer.
McCubrey JA; Rakus D; Gizak A; Steelman LS; Abrams SL; Lertpiriyapong K; Fitzgerald TL; Yang LV; Montalto G; Cervello M; Libra M; Nicoletti F; Scalisi A; Torino F; Fenga C; Neri LM; Marmiroli S; Cocco L; Martelli AM
Biochim Biophys Acta; 2016 Dec; 1863(12):2942-2976. PubMed ID: 27612668
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-148a suppresses epithelial-mesenchymal transition and invasion of pancreatic cancer cells by targeting Wnt10b and inhibiting the Wnt/β-catenin signaling pathway.
Peng L; Liu Z; Xiao J; Tu Y; Wan Z; Xiong H; Li Y; Xiao W
Oncol Rep; 2017 Jul; 38(1):301-308. PubMed ID: 28586066
[TBL] [Abstract][Full Text] [Related]
20. Wnt/beta-catenin pathway in hepatocellular carcinoma pathogenesis and liver physiology.
Cavard C; Colnot S; Audard V; Benhamouche S; Finzi L; Torre C; Grimber G; Godard C; Terris B; Perret C
Future Oncol; 2008 Oct; 4(5):647-60. PubMed ID: 18922122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
